TTop stories Read More 2025 FDA approvalsJanuary 3, 2026 Drug developers secured approvals for 46 new therapeutic agents from the FDA’s Center for Drug Evaluation and Research…
HHeadlines Read More Selective depletion of tumor-associated SAMHD1 enhances chemotherapeutic efficacy and antitumor immune responsesDecember 15, 2025 Study approval All experimental animal procedures were performed in compliance with the Chinese. The study was conducted in…
HHeadlines Read More Integrating untargeted volatile metabolomics and molecular evidence supporting chemotaxonomy in Kaempferia species for more effective identificationAugust 31, 2025 Elshamy, I. A. et al. Recent advances in Kaempferia phytochemistry and biological activity: A comprehensive review. Nutrients 11,…
HHeadlines Read More miRNA biomarkers for prognosis and therapy monitoring in a multi-ethnic cohort with SARS-CoV-2 infectionAugust 21, 2025 Patient demographics This study encompassed a total of 31 control individuals (23 males (74.2%) and 8 females (25.8%),…